Publications by authors named "Kurt R Oettel"

Claim this Profile
B
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.
Brian Bourbeau, Gary H Lyman, Xiudong Jennifer Lei, Lee Jones, Jon Rosenthal, Kurt R Oettel

JCO Oncol Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
Nathan A Pennell, Melissa Dillmon, Laura A Levit, E Allyn Moushey, Ajjai S Alva, Kurt R Oettel

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are We on the Same Page? Patient and Provider Perceptions About Exercise in Cancer Care: A Focus Group Study.
Agnes Smaradottir, Angela L Smith, Andrew J Borgert, Kurt R Oettel

J Natl Compr Canc Netw· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.
Tien Hoang, Toby C Campbell, Chong Zhang, Kyungmann Kim, Jill M Kolesar, Kurt R Oettel

Invest New Drugs· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Anne M Traynor, Tracey L Weigel, Kurt R Oettel, David T Yang, Chong Zhang

Lung Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
Steven Attia, Anne M Traynor, Kyungmann Kim, Joseph J Merchant, Tien Hoang, Kurt R Oettel

J Thorac Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A morphealike skin condition caused by Borrelia burgdorferi in an immunocompromised patient.
Jeffrey S Sartin, Kurt R Oettel

Mayo Clin Proc· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.
Tien Hoang, KyungMann Kim, Joseph Merchant, Anne M Traynor, James McGovern, Kurt R Oettel

J Thorac Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis